NewAmsterdam Pharma Co. N.V. (NAMS)
Market Closed
17 Jul, 20:00
$
31. 68
+0.63
+2.029%
$
4.12B Market Cap
- P/E Ratio
- Div Yield
704,400 Volume
-1.92 Eps
$ 31.05
Previous Close 
Want to track NAMS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NewAmsterdam Pharma Co. N.V. (NAMS) Statistics
Valuation metrics
Market Cap 4.12B
Enterprise value 3.25B
Trailing P/E (ttm) -17.5
Forward P/E -
PEG ratio 2.91
Price/Sales (ttm) 164.13
Price/Book (mrq) 5.77
Enterprise Value/Revenue 143.85
Enterprise Value/EBITDA -15.27
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 690.48K
Average volume (90 days) 1.36M
Price summary
52-Week low 20.53
52-Week high 42.2
Beta -
50-Day moving average 31.34
200-Day moving average 32.99
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -9.43%
Operating margin -9.54%
Operational effectiveness
Return on assets -0.29%
Return on equity -0.3%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.19
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.76
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.25
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 9.76%
Book value per share (mrq) 5.49
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
